Literature DB >> 7986961

Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence.

G N Tytgat1.   

Abstract

Healing the gastroduodenal mucosa through Helicobacter pylori eradication leads to a dramatic reduction in gastroduodenal ulcer relapse. Eradication of H. pylori proves to be difficult. Although the organism is sensitive to many antibiotics in vitro, the in vivo eradicating efficacy is often disappointing. This overview summarizes the most commonly used currently-available eradication schemes and the consequences of successful eradication in peptic ulcer disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986961     DOI: 10.1111/j.1365-2036.1994.tb00303.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  34 in total

Review 1.  Helicobacter pylori.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

2.  Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients.

Authors:  D J Kearney; A Brousal
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

3.  Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations.

Authors:  Tsukasa Uno; Takenori Niioka; Makoto Hayakari; Norio Yasui-Furukori; Kazunobu Sugawara; Tomonori Tateishi
Journal:  Eur J Clin Pharmacol       Date:  2007-01-04       Impact factor: 2.953

4.  Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection.

Authors:  Takeshi Hagiwara; Mototsugu Kato; Tomonori Anbo; Akimichi Imamura; Toshihiro Suga; Takumi Uchida; Akira Fujinaga; Manabu Nakagawa; Soichi Nakagawa; Yuichi Shimizu; Jyunji Yamamoto; Hiroshi Takeda; Masahiro Asaka
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

5.  Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.

Authors:  M Tavakoli; A T Prach; M Malek; D Hopwood; B W Senior; F E Murray
Journal:  Pharmacoeconomics       Date:  1999-10       Impact factor: 4.981

6.  A sensitive and specific PCR method to detect Helicobacter felis in a conventional mouse model.

Authors:  L Kong; J G Smith; D Bramhill; G K Abruzzo; C Bonfiglio; C Cioffe; A M Flattery; C J Gill; L Lynch; P M Scott; L Silver; C Thompson; H Kropp; K Bartizal
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

7.  CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability.

Authors:  T Kita; Y Tanigawara; N Aoyama; T Hohda; Y Saijoh; F Komada; T Sakaeda; K Okumura; T Sakai; M Kasuga
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

8.  Influence of age, comorbidity, type of operation and other variables on lethality and duration of post-operative hospital stay in patients with peptic ulcer. An analysis of 303 surgically treated patients.

Authors:  J Högel; R J Rieker; R Eisele; E Schmid
Journal:  Langenbecks Arch Chir       Date:  1996

9.  Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.

Authors:  A H Briggs; M J Sculpher; R P Logan; J Aldous; M E Ramsay; J H Baron
Journal:  BMJ       Date:  1996-05-25

Review 10.  Diagnostic methods for Helicobacter pylori detection and eradication.

Authors:  A F Goddard; R P H Logan
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.